Hans Biomed

Hans Biomed Dividend Coverage

The Dividend Coverage Ratio of Hans Biomed (042520.KQ) as of Nov 3, 2026 is 8.41. In the previous year, Dividend Coverage Ratio was 4.09 — a change of 105.47% (higher).

Dividend Coverage

8.41

YoY

105.47%

Last updated:

Dividend Coverage Ratio of Hans Biomed is 2019 8.41 . Dividend Coverage Ratio of Hans Biomed was 2018 4.09 . It decreases by 105.47% higher compared to the previous year.

The Hans Biomed Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2014
5.00 KRW
Jan 1, 2015
7.01 KRW
Jan 1, 2016
4.91 KRW
Jan 1, 2017
8.31 KRW
Jan 1, 2018
4.09 KRW
Jan 1, 2019
8.41 KRW
The Hans Biomed Dividend Coverage history
YEARDividend CoverageYoY
8.41+105.47%
4.09-50.77%
8.31+69.25%
4.91-29.97%
7.01+40.37%
5.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hans Biomed Stock analysis

What does Hans Biomed do? Hans Biomed Corp manufactures and sells graft material and silicon products under brand names SureDerm, BellaGen, and GPS for skin-implant materials used in burn treatment and skin graft. The company offers bone-implant materials including allogeneic bones, xenogenous bones, and synthetic bones under SureFuse, ExFuse, and SureOss for dentistry and orthopedic applications. Silicone products such as BellaGel and Scar Clinic are utilized for scar treatment and breast implants. The firm also provides hair transplanters as part of its product portfolio. Skin-implant materials under SureDerm, BellaGen, and GPS are purchased by medical facilities for burn treatment and skin graft procedures. Bone-implant materials under SureFuse, ExFuse, and SureOss are bought by dental and orthopedic clinics for various surgical needs. Silicone products BellaGel and Scar Clinic are acquired by healthcare providers for scar management and breast implant surgeries. Hair transplanters are sold to medical institutions requiring such equipment. The company's primary revenue streams come from the sale of skin-implant materials, bone-implant materials, and silicone products across medical, dental, and orthopedic sectors. Medical facilities, dental clinics, and orthopedic practices represent key customer segments. Brand names SureDerm, BellaGen, GPS, SureFuse, ExFuse, SureOss, BellaGel, and Scar Clinic drive product differentiation and market positioning in the healthcare industry. Hans Biomed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hans Biomed stock

Dividend Coverage Ratio of Hans Biomed is 8.41 in 2019.

Dividend Coverage Ratio of Hans Biomed changed from 4.09 to 8.41, representing a 105.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Hans Biomed since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Hans Biomed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Hans Biomed

All Key Metrics — Hans Biomed